Back

Latest Forum Topics / Alset    Last:0.021    +0.001

Post Reply

Singapore-eDev Post Reply Rate topic
zulakuma86 Member	19-Aug-2020 23:02        zulakuma86 About Contact  Quote this Post!
x 0   x 0  Alert Admin	1.company began nego to out license = price increase abit 2. Deal inked to conduct trial = price increase more 3. Trial success = multi bagger If only we know anyone working for Ah Chan.....
Useful To Me  Not Useful To Me
zulakuma86 Member	19-Aug-2020 22:50        zulakuma86 About Contact  Quote this Post!
x 0   x 0  Alert Admin	Thank you for writting in, a pragmatic person you are. So they are looking to license out Equivir. I am wondering how aggresive they are in looking for company to in-license. And if at the moment they are in the process of negotiations. Looking at the current fast pace rate of covid trials globally, if Equivir really proved effective plus data backing them, i am sure in a month or two they can out license Equivir. If scientific results doesnt show significant p-value, it will be difficult to out license to develop Equivir clinically. UNLESS they get investors so they can run their own clinical trial. Again, i have a good feel on this one. Even though Chan keeps on annoying us. SINGKg      ( Date: 19-Aug-2020 18:00) Posted: Email query to SeD????? Dear Sir/Mdm, Good day to you. I am writing in as an investor of Singapore eDevelopment and Document Security Systems. I would like to congratulate you all on the completion of the latest R&D project (Equivir / Linebacker / 3F Biofragance eg.) and share swap approval recently. I am really excited for you guys. Could you also shed some light on what are the status of the mentioned covid antiviral drugs in regards to drug trial (phase 1/2/3) or any talks with potential buyers? Thank you. Email response from SeD????? Thank you for writing in and we appreciate your support in Singapore eDevelopment. For Singapore eDevelopment, the company's current objective is to establish strong novel research data which it will use to source and secure licensing deals with major pharmaceutical companies for further clinical development its suite of drugs. For Equivir for example, the drug is currently in the pre-clinical stage of development and has proved in vitro success against COVID-19 in independent laboratory testing. These in vitro results also confirms the predictions of earlier advanced computational molecular docking studies utilising advanced computational models, which indicates that Equivir successfully inhibits infection of SARS-CoV-2, the virus responsible for the COVID-19 outbreak. Presently, SeD is in position and ready to license Equivir to suitable pharmaceutical companies to further Equivir?s development through clinical trials in humans. Apart from recent press statements announced, the company is unable to comment further on the status of its biomedical portfolio of drugs as it may constitute non-public information that may not be selectively disclosed as per SGX listing rules. That said, relevant announcements will be made in a timely manner as and when there are material developments. Hope this clarifies! End of email response????
Useful To Me  Not Useful To Me
Superfast Supreme	19-Aug-2020 19:09        Superfast About Contact  Quote this Post!
x 0   x 0  Alert Admin	Hee hee.... Pick durians... RyantNg      ( Date: 19-Aug-2020 19:04) Posted: So which mean die liao is it? better sell all
Useful To Me  Not Useful To Me
RyantNg Senior	19-Aug-2020 19:04        RyantNg About Contact  Quote this Post!
x 0   x 0  Alert Admin	So which mean die liao is it? better sell all
Useful To Me  Not Useful To Me
TeoMark Veteran	19-Aug-2020 19:04        TeoMark About Contact  Quote this Post!
x 0   x 0  Alert Admin	Pick durian. Later he treat you jiak ang moh liu lian ah. Superfast      ( Date: 19-Aug-2020 18:58) Posted: Alamak.... If too honest, how to pick cheap durians ? TeoMark      ( Date: 19-Aug-2020 18:39) Posted: Presently, SeD is in position and ready to license Equivir to suitable pharmaceutical companies to further Equivir?s development through clinical trials in humans. Reading this you already should know nothing is been done so far. When you say 'Is in position and ready to'. Thats a passive statement. If there are action, they would have said 'is actively looking for'.
Useful To Me  Not Useful To Me
Superfast Supreme	19-Aug-2020 18:58        Superfast About Contact  Quote this Post!
x 0   x 0  Alert Admin	Alamak.... If too honest, how to pick cheap durians ? TeoMark      ( Date: 19-Aug-2020 18:39) Posted: Presently, SeD is in position and ready to license Equivir to suitable pharmaceutical companies to further Equivir?s development through clinical trials in humans. Reading this you already should know nothing is been done so far. When you say 'Is in position and ready to'. Thats a passive statement. If there are action, they would have said 'is actively looking for'.
Useful To Me  Not Useful To Me
Superfast Supreme	19-Aug-2020 18:57        Superfast About Contact  Quote this Post!
x 0   x 0  Alert Admin	狐 狸 都 没 吃 饱 啊 ?～ 等 狐 狸 吃 饱 先 丫 ?～ Ushnisambatha      ( Date: 19-Aug-2020 18:33) Posted: 小 时 候 ， 在 海 低 ， 妈 妈 有 提 醒 ， 游 大 海 ， 要 小 心 ， 老 鲨 无 留 情 ， 至 今 思 ， 我 还 活 ， 因 学 游 他 边 ， 他 那 向 ， 我 一 样 ， 永 远 不 变 粮 。 Superfast      ( Date: 19-Aug-2020 18:04) Posted: Hmmm.... See 10c then we know how's it goes la... Probabl
Useful To Me  Not Useful To Me
TeoMark Veteran	19-Aug-2020 18:39        TeoMark About Contact  Quote this Post!
x 0   x 0  Alert Admin	Presently, SeD is in position and ready to license Equivir to suitable pharmaceutical companies to further Equivir?s development through clinical trials in humans. Reading this you already should know nothing is been done so far. When you say 'Is in position and ready to'. Thats a passive statement. If there are action, they would have said 'is actively looking for'.
Useful To Me  Not Useful To Me
Ushnisambatha Senior	19-Aug-2020 18:33        Ushnisambatha About Contact  Quote this Post!
x 0   x 0  Alert Admin	小 时 候 ， 在 海 低 ， 妈 妈 有 提 醒 ， 游 大 海 ， 要 小 心 ， 老 鲨 无 留 情 ， 至 今 思 ， 我 还 活 ， 因 学 游 他 边 ， 他 那 向 ， 我 一 样 ， 永 远 不 变 粮 。 Superfast      ( Date: 19-Aug-2020 18:04) Posted: Hmmm.... See 10c then we know how's it goes la... Probably SINGKg      ( Date: 19-Aug-2020 18:00) Posted: Email query to SeD????? Dear Sir/Mdm, Good day to you. I am writing in as an investor of Singapore eDevelopment and Document Security Systems. I would like to congratulate you all on the completion of the latest R&D project (Equivir / Linebacker / 3F Biofragance eg.) and share swap approval recently. I am really excited for you guys. Could you also shed some light on what are the status of the mentioned covid antiviral drugs in regards to drug trial (phase 1/2/3) or any talks with potential buyers? Thank you. Email response from SeD????? Thank you for writing in and we appreciate your support in Singapore eDevelopment. For Singapore eDevelopment, the company's current objective is to establish strong novel research data which it will use to source and secure licensing deals with major pharmaceutical companies for further clinical development its suite of drugs. For Equivir for example, the drug is currently in the pre-clinical stage of development and has proved in vitro success against COVID-19 in independent laboratory testing. These in vitro results also confirms the predictions of earlier advanced computational molecular docking studies utilising advanced computational models, which indicates that Equivir successfully inhibits infection of SARS-CoV-2, the virus responsible for the COVID-19 outbreak. Presently, SeD is in position and ready to license Equivir to suitable pharmaceutical companies to further Equivir?s development through clinical trials in humans. Apart from recent press statements announced, the company is unable to comment further on the status of its biomedical portfolio of drugs as it may constitute non-public information that may not be selectively disclosed as per SGX listing rules. That said, relevant announcements will be made in a timely manner as and when there are material developments. Hope this clarifies! End of email response????
Useful To Me  Not Useful To Me
Superfast Supreme	19-Aug-2020 18:26        Superfast About Contact  Quote this Post!
x 0   x 0  Alert Admin	That's the real intention mAh.... collect cheap durians... trademaster      ( Date: 19-Aug-2020 18:24) Posted: This is gd news... now px too cheap, nobody dare to buy lol SINGKg      ( Date: 19-Aug-2020 18:00) Posted: Email query to SeD????? Dear Sir/Mdm, Good day to you. I am writing in as an investor of Singapore eDevelopment and Document Security Systems. I would like to congratulate you all on the completion of the latest R&D project (Equivir / Linebacker / 3F Biofragance eg.) and share swap approval recently. I am really excited for you guys. Could you also shed some light on what are the status of the mentioned covid antiviral drugs in regards to drug trial (phase 1/2/3) or any talks with potential buyers? Thank you. Email response from SeD????? Thank you for writing in and we appreciate your support in Singapore eDevelopment. For Singapore eDevelopment, the company's current objective is to establish strong novel research data which it will use to source and secure licensing deals with major pharmaceutical companies for further clinical development its suite of drugs. For Equivir for example, the drug is currently in the pre-clinical stage of development and has proved in vitro success against COVID-19 in independent laboratory testing. These in vitro results also confirms the predictions of earlier advanced computational molecular docking studies utilising advanced computational models, which indicates that Equivir successfully inhibits infection of SARS-CoV-2, the virus responsible for the COVID-19 outbreak. Presently, SeD is in position and ready to license Equivir to suitable pharmaceutical companies to further Equivir?s development through clinical trials in humans. Apart from recent press statements announced, the company is unable to comment further on the status of its biomedical portfolio of drugs as it may constitute non-public information that may not be selectively disclosed as per SGX listing rules. That said, relevant announcements will be made in a timely manner as and when there are material developments. Hope this clarifies! End of email response????
Useful To Me  Not Useful To Me
trademaster Supreme	19-Aug-2020 18:24        trademaster About Contact  Quote this Post!
x 0   x 0  Alert Admin	This is gd news... now px too cheap, nobody dare to buy lol SINGKg      ( Date: 19-Aug-2020 18:00) Posted: Email query to SeD????? Dear Sir/Mdm, Good day to you. I am writing in as an investor of Singapore eDevelopment and Document Security Systems. I would like to congratulate you all on the completion of the latest R&D project (Equivir / Linebacker / 3F Biofragance eg.) and share swap approval recently. I am really excited for you guys. Could you also shed some light on what are the status of the mentioned covid antiviral drugs in regards to drug trial (phase 1/2/3) or any talks with potential buyers? Thank you. Email response from SeD????? Thank you for writing in and we appreciate your support in Singapore eDevelopment. For Singapore eDevelopment, the company's current objective is to establish strong novel research data which it will use to source and secure licensing deals with major pharmaceutical companies for further clinical development its suite of drugs. For Equivir for example, the drug is currently in the pre-clinical stage of development and has proved in vitro success against COVID-19 in independent laboratory testing. These in vitro results also confirms the predictions of earlier advanced computational molecular docking studies utilising advanced computational models, which indicates that Equivir successfully inhibits infection of SARS-CoV-2, the virus responsible for the COVID-19 outbreak. Presently, SeD is in position and ready to license Equivir to suitable pharmaceutical companies to further Equivir?s development through clinical trials in humans. Apart from recent press statements announced, the company is unable to comment further on the status of its biomedical portfolio of drugs as it may constitute non-public information that may not be selectively disclosed as per SGX listing rules. That said, relevant announcements will be made in a timely manner as and when there are material developments. Hope this clarifies! End of email response????
Useful To Me  Not Useful To Me
Ligaya Master	19-Aug-2020 18:15        Ligaya About Contact  Quote this Post!
x 0   x 0  Alert Admin	thks bro, at least this reply has the substance SINGKg      ( Date: 19-Aug 18:00) Posted: Email query to SeD????? Dear Sir/Mdm, Good day to you. I am writing in as an investor of Singapore eDevelopment and Document Security Systems. I would like to congratulate you all on the completion of the latest R&D project (Equivir / Linebacker / 3F Biofragance eg.) and share swap approval recently. I am really excited for you guys. Could you also shed some light on what are the status of the mentioned covid antiviral drugs in regards to drug trial (phase 1/2/3) or any talks with potential buyers? Thank you. Email response from SeD????? Thank you for writing in and we appreciate your support in Singapore eDevelopment. For Singapore eDevelopment, the company's current objective is to establish strong novel research data which it will use to source and secure licensing deals with major pharmaceutical companies for further clinical development its suite of drugs. For Equivir for example, the drug is currently in the pre-clinical stage of development and has proved in vitro success against COVID-19 in independent laboratory testing. These in vitro results also confirms the predictions of earlier advanced computational molecular docking studies utilising advanced computational models, which indicates that Equivir successfully inhibits infection of SARS-CoV-2, the virus responsible for the COVID-19 outbreak. Presently, SeD is in position and ready to license Equivir to suitable pharmaceutical companies to further Equivir?s development through clinical trials in humans. Apart from recent press statements announced, the company is unable to comment further on the status of its biomedical portfolio of drugs as it may constitute non-public information that may not be selectively disclosed as per SGX listing rules. That said, relevant announcements will be made in a timely manner as and when there are material developments. Hope this clarifies! End of email response????
Useful To Me  Not Useful To Me
Superfast Supreme	19-Aug-2020 18:04        Superfast About Contact  Quote this Post!
x 0   x 0  Alert Admin	Hmmm.... See 10c then we know how's it goes la... Probably SINGKg      ( Date: 19-Aug-2020 18:00) Posted: Email query to SeD????? Dear Sir/Mdm, Good day to you. I am writing in as an investor of Singapore eDevelopment and Document Security Systems. I would like to congratulate you all on the completion of the latest R&D project (Equivir / Linebacker / 3F Biofragance eg.) and share swap approval recently. I am really excited for you guys. Could you also shed some light on what are the status of the mentioned covid antiviral drugs in regards to drug trial (phase 1/2/3) or any talks with potential buyers? Thank you. Email response from SeD????? Thank you for writing in and we appreciate your support in Singapore eDevelopment. For Singapore eDevelopment, the company's current objective is to establish strong novel research data which it will use to source and secure licensing deals with major pharmaceutical companies for further clinical development its suite of drugs. For Equivir for example, the drug is currently in the pre-clinical stage of development and has proved in vitro success against COVID-19 in independent laboratory testing. These in vitro results also confirms the predictions of earlier advanced computational molecular docking studies utilising advanced computational models, which indicates that Equivir successfully inhibits infection of SARS-CoV-2, the virus responsible for the COVID-19 outbreak. Presently, SeD is in position and ready to license Equivir to suitable pharmaceutical companies to further Equivir?s development through clinical trials in humans. Apart from recent press statements announced, the company is unable to comment further on the status of its biomedical portfolio of drugs as it may constitute non-public information that may not be selectively disclosed as per SGX listing rules. That said, relevant announcements will be made in a timely manner as and when there are material developments. Hope this clarifies! End of email response????
Useful To Me  Not Useful To Me
Superfast Supreme	19-Aug-2020 18:02        Superfast About Contact  Quote this Post!
x 0   x 0  Alert Admin	Alamak... He collect cheap durians not enough meh...~ RyantNg      ( Date: 19-Aug-2020 17:59) Posted: Just now too busy fighting fire in the kitchen. ohhh, as Chan up 2 steps down 2 step. sure will go up up Superfast      ( Date: 19-Aug-2020 17:28) Posted: Alamak... Ur towkay din tell u
Useful To Me  Not Useful To Me
hantanbl Senior	19-Aug-2020 18:01        hantanbl About Contact  Quote this Post!
x 0   x 0  Alert Admin	Ah Chan don't sing this song He only sing 'here we go again.....' SINGKg      ( Date: 19-Aug-2020 17:42) Posted: My sentiment towards SeD... 最 爱 你 的 人 是 我 你 怎 么 舍 得 我 难 过 在 我 最 需 要 你 的 时 候 没 有 一 句 话 就 走 最 爱 你 的 人 是 我 你 怎 么 舍 得 我 难 过 对 你 付 出 了 这 么 多 你 却 没 有 感 动 过 ..
Useful To Me  Not Useful To Me
SINGKg Senior	19-Aug-2020 18:00        SINGKg About Contact  Quote this Post!
x 0   x 0  Alert Admin	Email query to SeD????? Dear Sir/Mdm, Good day to you. I am writing in as an investor of Singapore eDevelopment and Document Security Systems. I would like to congratulate you all on the completion of the latest R&D project (Equivir / Linebacker / 3F Biofragance eg.) and share swap approval recently. I am really excited for you guys. Could you also shed some light on what are the status of the mentioned covid antiviral drugs in regards to drug trial (phase 1/2/3) or any talks with potential buyers? Thank you. Email response from SeD????? Thank you for writing in and we appreciate your support in Singapore eDevelopment. For Singapore eDevelopment, the company's current objective is to establish strong novel research data which it will use to source and secure licensing deals with major pharmaceutical companies for further clinical development its suite of drugs. For Equivir for example, the drug is currently in the pre-clinical stage of development and has proved in vitro success against COVID-19 in independent laboratory testing. These in vitro results also confirms the predictions of earlier advanced computational molecular docking studies utilising advanced computational models, which indicates that Equivir successfully inhibits infection of SARS-CoV-2, the virus responsible for the COVID-19 outbreak. Presently, SeD is in position and ready to license Equivir to suitable pharmaceutical companies to further Equivir?s development through clinical trials in humans. Apart from recent press statements announced, the company is unable to comment further on the status of its biomedical portfolio of drugs as it may constitute non-public information that may not be selectively disclosed as per SGX listing rules. That said, relevant announcements will be made in a timely manner as and when there are material developments. Hope this clarifies! End of email response????
Useful To Me  Not Useful To Me
RyantNg Senior	19-Aug-2020 17:59        RyantNg About Contact  Quote this Post!
x 0   x 0  Alert Admin	Just now too busy fighting fire in the kitchen. ohhh, as Chan up 2 steps down 2 step. sure will go up up Superfast      ( Date: 19-Aug-2020 17:28) Posted: Alamak... Ur towkay din tell u ? RyantNg      ( Date: 19-Aug-2020 16:22) Posted: Liao, free ride again
Useful To Me  Not Useful To Me
SINGKg Senior	19-Aug-2020 17:42        SINGKg About Contact  Quote this Post!
x 0   x 0  Alert Admin	My sentiment towards SeD... 最 爱 你 的 人 是 我 你 怎 么 舍 得 我 难 过 在 我 最 需 要 你 的 时 候 没 有 一 句 话 就 走 最 爱 你 的 人 是 我 你 怎 么 舍 得 我 难 过 对 你 付 出 了 这 么 多 你 却 没 有 感 动 过 ..
Useful To Me  Not Useful To Me
guards80 Supreme	19-Aug-2020 17:40        guards80 About Contact  Quote this Post!
x 0   x 0  Alert Admin	Must be see medtec plunge fast that follow. Down fast Superfast      ( Date: 19-Aug-2020 17:39) Posted: Play along ... If got xtra... Money 💰 If u believe.... Most importantly.... Must HV patience to play... guards80      ( Date: 19-Aug-2020 17:37) Posted: What i know is below 55 is a bu
Useful To Me  Not Useful To Me
guards80 Supreme	19-Aug-2020 17:39        guards80 About Contact  Quote this Post!
x 0   x 0  Alert Admin	play range 5x to 6x. Above 70 wait long long 98mich98      ( Date: 19-Aug-2020 17:38) Posted: false impression tat if can get 5.2c, it will jump back to 6.8c. This time maybe con us again. Beware if want to load again. I prefer 4.5 c to average.
Useful To Me  Not Useful To Me

                                                         First   < Newer   1481-1500 of 8048   Older>   Last